Incidence of infections, cardiac events, neurological toxicity and cytokine response syndrome (CRS) in patients treated with chimeric antigen receptor (CAR) T cell therapy: A 3-year nationwide analysis.

Himil Mahadevia, Furha Cossor, Parth Sharma et al.|Journal of Clinical Oncology|2025

Cited by 1